Evaluation of two population screening programmes for BRCA1/2 founder mutations in the Australian Jewish community: a protocol paperNicole E Cousens, Jane Tiller, Bettina Meiser, Kristine Barlow-Stewart, Simone Rowley, Yi-An Ko, Sakshi Mahale, Ian G Campbell, Rajneesh Kaur, Agnes Bankier, Leslie Burnett, Chris Jacobs, Paul A James, Alison Trainer, Suzanne Neil, Martin B Delatycki, Lesley Andrews
25 June 2021
Pharmacogenetics to Avoid Loss of Hearing (PALOH) trial: a protocol for a prospective observational implementation trialJohn Henry McDermott, Rachel Mahood, Duncan Stoddard, Ajit Mahaveer, Mark A Turner, Rachel Corry, Julia Garlick, Gino Miele, Shaun Ainsworth, Laura Kemp, Iain Bruce, Richard Body, Fiona Ulph, Rhona Macleod, Karen Harvey, Nicola Booth, Peter Roberts, Paul Wilson, William G Newman
16 June 2021
Does geographical variation confound the relationship between host factors and the human gut microbiota: a population-based study in ChinaShan Sun, Huijun Wang, Matthew CB Tsilimigras, Annie Green Howard, Wei Sha, Jiguo Zhang, Chang Su, Zhihong Wang, Shufa Du, Michael Sioda, Farnaz Fouladi, Anthony Fodor, Penny Gordon-Larsen, Bing Zhang
19 November 2020
Randomised multicentre clinical trial to evaluate voriconazole pre-emptive genotyping strategy in patients with risk of aspergillosis: vorigenipharm study protocolJaime Monserrat Villatoro, Irene García García, David Bueno, Rafael de la Cámara, Miriam Estébanez, Ana López de la Guía, Francisco Abad-Santos, Cristina Antón, Gina Mejía, María José Otero, Elena Ramírez García, Jesús Frías Iniesta, Antonio Carcas, Alberto M Borobia
1 October 2020
Implementing a pharmacogenetic-driven algorithm to guide dual antiplatelet therapy (DAPT) in Caribbean Hispanics: protocol for a non-randomised clinical trialDagmar F Hernandez-Suarez, Kyle Melin, Frances Marin-Maldonado, Hector J Nunez, Ariel F Gonzalez, Lorena Gonzalez-Sepulveda, Sona Rivas-Tumanyan, Hetanshi Naik, Gualberto Ruaño, Stuart A Scott, Jorge Duconge
6 August 2020
When to break the news and whose responsibility is it? A cross-sectional qualitative study of health professionals’ views regarding disclosure of BRCA genetic cancer riskAlison Luk Young, Phyllis N Butow, Katherine M Tucker, Claire E Wakefield, Emma Healey, Rachel Williams
25 February 2020
Delivering genome sequencing in clinical practice: an interview study with healthcare professionals involved in the 100 000 Genomes ProjectSaskia C Sanderson, Melissa Hill, Christine Patch, Beverly Searle, Celine Lewis, Lyn S Chitty
3 November 2019
Health outcomes, utility and costs of returning incidental results from genomic sequencing in a Canadian cancer population: protocol for a mixed-methods randomised controlled trialSalma Shickh, Marc Clausen, Chloe Mighton, Mariana Gutierrez Salazar, Kathleen-Rose Zakoor, Rita Kodida, Emma Reble, Christine Elser, Andrea Eisen, Seema Panchal, Melyssa Aronson, Tracy Graham, Susan Randall Armel, Chantal F Morel, Ramzi Fattouh, Emily Glogowski, Kasmintan A Schrader, Jada G Hamilton, Kenneth Offit, Mark Robson, June C Carroll, Wanrudee Isaranuwatchai, Raymond H Kim, Jordan Lerner-Ellis, Kevin E Thorpe, Andreas Laupacis, Yvonne Bombard,
7 October 2019
Psychosocial problems in women attending French, German and Spanish genetics clinics before and after targeted or multigene testing results: an observational prospective studyAnne Brédart, Jean-Luc Kop, Julia Dick, Alejandra Cano, Antoine De Pauw, Amélie Anota, Joan Brunet, Peter Devilee, Dominique Stoppa-Lyonnet, Rita Schmutzler, Sylvie Dolbeault
24 September 2019
Comprehensive evaluation of a prospective Australian patient cohort with suspected genetic kidney disease undergoing clinical genomic testing: a study protocolKushani Jayasinghe, Zornitza Stark, Chirag Patel, Amali Mallawaarachchi, Hugh McCarthy, Randall Faull, Aron Chakera, Madhivanan Sundaram, Matthew Jose, Peter Kerr, You Wu, Louise Wardrop, Ilias Goranitis, Stephanie Best, Melissa Martyn, Catherine Quinlan, Andrew J Mallett
5 August 2019